Literature DB >> 11095513

VEGF release by retinal glia depends on both oxygen and glucose supply.

W Eichler1, H Kuhrt, S Hoffmann, P Wiedemann, A Reichenbach.   

Abstract

Isolated retinae or isolated Müller cells were cultured in vitro, and vascular endothelial growth factor (VEGF) was assayed as protein (by ELISA) and as mRNA (by semi-quantitative RT-PCR). In both types of cultures, hypoxia (5% O2) resulted in an upregulated VEGF release. While the unstimulated VEGF secretion was virtually independent of glucose (0.125 - 25 mM), elevated glucose concentrations (10 - 25 mM) blocked most of the stimulatory effect of hypoxia on VEGF mRNA synthesis (determined in Müller cell cultures) as well as on VEGF release (in both retina and Müller cell cultures). It is concluded that in retinal glial (Müller) cells, being responsible for retinal VEGF synthesis (and, thus, for undesirable neovascularization), the metabolic effects of hypoxia can be compensated by a surplus of glucose.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095513     DOI: 10.1097/00001756-200011090-00026

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  22 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

3.  Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease.

Authors:  Ophélie Vacca; Brahim El Mathari; Marie Darche; José-Alain Sahel; Alvaro Rendon; Deniz Dalkara
Journal:  J Vis Exp       Date:  2015-04-19       Impact factor: 1.355

Review 4.  The role of Müller cell glucocorticoid signaling in diabetic retinopathy.

Authors:  Farhad Ghaseminejad; Lew Kaplan; Anna M Pfaller; Stefanie M Hauck; Antje Grosche
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-16       Impact factor: 3.117

5.  The retina as a novel in vivo model for studying the role of molecules of the Bcl-2 family in relation to MPTP neurotoxicity.

Authors:  S T Chen; J R Hsu; P C Hsu; J I Chuang
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

6.  Aralia elata inhibits neurodegeneration by downregulating O-GlcNAcylation of NF-κB in diabetic mice.

Authors:  Seong-Jae Kim; Min-Jun Kim; Mee-Young Choi; Yoon-Sook Kim; Ji-Myong Yoo; Eun-Kyung Hong; Sunmi Ju; Wan-Sung Choi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

7.  Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy.

Authors:  Xialin Liu; Yongjun Li; Yizhi Liu; Yan Luo; Dingding Wang; Brian H Annex; Pascal J Goldschmidt-Clermont
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

Review 8.  Neuropeptides and diabetic retinopathy.

Authors:  Robert Gábriel
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

9.  Hypoglycemia reduces vascular endothelial growth factor A production by pancreatic beta cells as a regulator of beta cell mass.

Authors:  Xiangwei Xiao; Ping Guo; Zean Chen; Yousef El-Gohary; John Wiersch; Iljana Gaffar; Krishna Prasadan; Chiyo Shiota; George K Gittes
Journal:  J Biol Chem       Date:  2013-02-01       Impact factor: 5.157

10.  Functional implication of Dp71 in osmoregulation and vascular permeability of the retina.

Authors:  Abdoulaye Sene; Ramin Tadayoni; Thomas Pannicke; Antje Wurm; Brahim El Mathari; Romain Benard; Michel Joseph Roux; David Yaffe; Dominique Mornet; Andreas Reichenbach; Jose-Alain Sahel; Alvaro Rendon
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.